Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Flow Cytometry / methods*
• Humans
• Leukemia, Myeloid, Acute / drug therapy*
• Molecular Diagnostic Techniques
• Neoplasm, Residual / blood*
• Neoplasm, Residual / diagnosis*
• Neoplasm, Residual / etiology
• Prognosis
• Survival Rate